Dynamics of brain iron levels in multiple sclerosis

Objective: We investigated longitudinal changes in iron concentration in the subcortical gray matter (caudate nucleus, globus pallidus, putamen, thalamus) of patients with clinically isolated syndrome (CIS) and definite multiple sclerosis (MS) and their relation to clinical and other morphologic variables. Methods: We followed 144 patients (76 CIS; median Expanded Disability Status Scale [EDSS] 1.0 [interquartile range (IQR) 0.0–2.0]; 68 MS; median EDSS 2.0 [IQR 1.0–3.3]) clinically and with 3T MRI over a median period of 2.9 (IQR 1.3–4.0) years. Iron concentration was determined by R2* relaxometry at baseline and last follow-up. Results: At baseline, subcortical gray matter iron deposition was higher in MS compared to CIS. In CIS, R2* rates increased in the globus pallidus (p < 0.001), putamen (p < 0.001), and caudate nucleus (p < 0.001), whereas R2* rates in the thalamus decreased (p < 0.05). In MS, R2* rates increased in the putamen (p < 0.05), remained stable in the globus pallidus and caudate nucleus, and decreased in the thalamus (p < 0.01). Changes in R2* relaxation rates were unrelated to changes in the volume of respective structures, of T2 lesion load, and of disability. Conclusions: Iron accumulation in the basal ganglia is more pronounced in the early than later phases of the disease and occurs independent from other morphologic brain changes. Short-term changes in iron concentration are not associated with disease activity or changes in disability.

[1]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[2]  Rohit Bakshi,et al.  Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. , 2005, Archives of neurology.

[3]  D.L. Plummer,et al.  DispImage: Un mezzo di analisi e presentazione per iconografia medica , 1992 .

[4]  Ludwig Kappos,et al.  Multicenter R2* mapping in the healthy brain , 2014, Magnetic resonance in medicine.

[5]  M. Neema,et al.  Iron and multiple sclerosis , 2014, Neurobiology of Aging.

[6]  Steven M LeVine,et al.  Pathogenic implications of iron accumulation in multiple sclerosis , 2012, Journal of neurochemistry.

[7]  T. Rouault,et al.  Iron metabolism in the CNS: implications for neurodegenerative diseases , 2013, Nature Reviews Neuroscience.

[8]  Simon Hametner,et al.  Iron and neurodegeneration in the multiple sclerosis brain , 2013, Annals of neurology.

[9]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[10]  D. Kell Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases , 2008, BMC Medical Genomics.

[11]  C. W. Adams,et al.  Perivascular iron deposition and other vascular damage in multiple sclerosis. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[12]  S Ropele,et al.  Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing–remitting multiple sclerosis , 2009, Multiple sclerosis.

[13]  David Pitt,et al.  Iron Is a Sensitive Biomarker for Inflammation in Multiple Sclerosis Lesions , 2013, PloS one.

[14]  Jeff F. Dunn,et al.  Iron in multiple sclerosis: roles in neurodegeneration and repair , 2014, Nature Reviews Neurology.

[15]  S Ropele,et al.  Determinants of brain iron in multiple sclerosis , 2011, Neurology.

[16]  S. Ropele,et al.  Quantitative MR imaging of brain iron: a postmortem validation study. , 2010, Radiology.

[17]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[18]  W Craelius,et al.  Iron deposits surrounding multiple sclerosis plaques. , 1982, Archives of pathology & laboratory medicine.

[19]  Rohit Bakshi,et al.  Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.

[20]  Hellmut Merkle,et al.  Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. , 2011, Brain : a journal of neurology.

[21]  P. Matthews,et al.  Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE‐ε4 , 2004, Annals of neurology.

[22]  Stephen M. Smith,et al.  A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.

[23]  S. Lynch,et al.  Iron chelation and multiple sclerosis , 2013, ASN neuro.

[24]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[25]  Margit Jehna,et al.  Quantitative susceptibility mapping in multiple sclerosis. , 2013, Radiology.

[26]  C. Enzinger,et al.  Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome , 2011, Multiple sclerosis.

[27]  Massimo Filippi,et al.  7. Mri Assessment of Iron Deposition in Multiple Sclerosis , 2022 .

[28]  D. Pennell,et al.  Myocardial T  2* measurements in iron‐overloaded thalassemia: An in vivo study to investigate optimal methods of quantification , 2008, Magnetic resonance in medicine.

[29]  R Marc Lebel,et al.  Multiple sclerosis: validation of MR imaging for quantification and detection of iron. , 2013, Radiology.

[30]  R Marc Lebel,et al.  Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease. , 2013, Radiology.

[31]  À. Rovira,et al.  MR brain iron mapping in MS , 2011, Neurology.

[32]  Jeffrey A. Cohen,et al.  Differential diagnosis of suspected multiple sclerosis: a consensus approach , 2008, Multiple sclerosis.

[33]  G. Salemi,et al.  Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity , 2005, Neurology.

[34]  Ludwig Kappos,et al.  Determinants of iron accumulation in deep grey matter of multiple sclerosis patients , 2014, Multiple sclerosis.